about
Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit.In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants.Pancreatic trauma in children.Intensive care unit environmental surfaces are contaminated by multidrug-resistant bacteria in biofilms: combined results of conventional culture, pyrosequencing, scanning electron microscopy, and confocal laser microscopy.Assessment of the selection process for myocutaneous flap repair and surgical complications in pelvic exenteration surgery.A new dry-surface biofilm model: An essential tool for efficacy testing of hospital surface decontamination procedures.Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma.Supraventricular tachycardia as a presenting feature of volvulus in a 15-month-old boy.Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair.Preoperative Botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia.Single port component separation: endoscopic external oblique release for complex ventral hernia repair.Preoperative chemical component relaxation using Botulinum toxin A: enabling laparoscopic repair of complex ventral hernia.Prevention of biofilm-induced capsular contracture with antibiotic-impregnated mesh in a porcine model.Laparoscopic repair of complex ventral hernia facilitated by pre-operative chemical component relaxation using Botulinum Toxin A.Single nucleotide primer extension (SNuPE) analysis of the G6PD gene in somatic cells and oocytes of a kangaroo (Macropus robustus)Right iliac fossa pain 10 years after appendicectomy and the diagnosis of stump appendicitisDetection of bacterial biofilm in double capsule surrounding mammary implants: findings in human and porcine breast augmentation
P50
Q34013314-6AA999E7-FEE8-49E0-9DFB-0A9AA3B2BFB8Q35133137-59AE10C9-CD58-4D94-87E1-5F9B11FE4A66Q35615867-2FC8A30D-1E5B-4024-8321-BBAAF04B80E7Q35695702-ECD91926-AD16-4282-9B5A-DD81F1BDEB8FQ38063156-DAACEC4C-E669-4603-82C7-52D17A976C99Q41060519-6A9857E6-7157-488D-9EFC-337D4B27BA94Q41669576-B83B0BB5-1FE2-40B7-B801-EFD4FBA30A59Q42718662-7D2072C7-786E-4D7C-8DBE-4DB3D4E6593EQ48150203-8FA6826A-DD38-4A92-ACDB-113C39243C72Q48585340-7A142682-08F7-4EFD-938A-DC38E9A78BEAQ49629953-80E01DFC-1C3A-4E4A-8AF5-3C538AC6E262Q51276451-A0E85B23-9E28-453A-A040-D6AA77EEB5DBQ51313682-B84CEB24-E9A6-41E3-B47D-E3C6B609BAC1Q51462441-2C378CEE-FA42-4B1D-92EB-B8553D15D594Q73996417-7C12315D-61BE-47BF-8F92-246CD7307D8EQ81973308-525DE9D9-6A44-40E6-AE1D-FB3E646AFECAQ83531520-F30DE788-DB12-47D6-B91F-F95CF095E79F
P50
description
researcher
@en
wetenschapper
@nl
name
A S Jacombs
@en
A S Jacombs
@nl
type
label
A S Jacombs
@en
A S Jacombs
@nl
prefLabel
A S Jacombs
@en
A S Jacombs
@nl
P106
P31
P496
0000-0002-5773-1993